(Q37893109)

English

Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system

scientific article published on October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

based on heuristic

inferred from title

end-stage liver disease

1 reference

based on heuristic

inferred from title

Yves-Patrice Le Treut

8

object named as

Yves-Patrice Le Treut

0 references

Jean-Charles Duclos-Vallée

5

object named as

Jean-Charles Duclos-Vallée

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

object named as

Claire Francoz

1

0 references

object named as

Jan Lerut

7

0 references

Dominique C Valla

object named as

Dominique Valla

14

0 references

object named as

Richard Moreau

9

0 references

object named as

Didier Samuel

12

0 references

author name string

Jacques Belghiti

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Denis Castaing

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Olivier Chazouillères

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Christophe Duvoux

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Yves-Patrice Le Treut

8

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ameet Mandot

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Georges Pageaux

11

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Dominique Thabut

13

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

François Durand

15

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Liver Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1137-1151

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

TIPS with expanded polytetrafluoroethylene-covered stent: results of an Italian multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Thoracocentesis. Clinical value, complications, technical problems, and patient experience.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hyponatremia and mortality among patients on the liver-transplant waiting list

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Newer approaches to therapy of hepatic encephalopathy

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Natural history of hepatopulmonary syndrome: Impact of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation for hepatopulmonary syndrome: a ten-year experience in Paris, France.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Pulmonary-Hepatic vascular Disorders (PHD).

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Pulmonary arterial hypertension in France: results from a national registry

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Improving prognosis following a first variceal haemorrhage over four decades

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Improved patient survival after acute variceal bleeding: a multicenter, cohort study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Epidemiology of viral hepatitis and HIV co-infection

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Are HIV-infected patients candidates for liver transplantation?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

EASL Clinical Practice Guidelines: management of cholestatic liver diseases.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Management of primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

The role of orthotopic liver transplantation in the management of sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Caroli's disease and outcomes after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Primary Budd-Chiari syndrome

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Multivariate analysis of prognostic factors in fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Early indicators of prognosis in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

MELD-XI: a rational approach to "sickest first" liver transplantation in cirrhotic patients requiring anticoagulant therapy

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver involvement in hereditary hemorrhagic telangiectasia (HHT).

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Extended liver resection for polycystic liver disease can challenge liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Surgical management of polycystic liver disease

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation for polycystic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Outcome and quality of life in patients with polycystic liver disease after liver or combined liver-kidney transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation in polycystic liver disease: a relevant treatment modality for adults?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Nutritional status: its influence on the outcome of patients undergoing liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Outcome of liver transplantation for familial amyloidotic polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

FDG PET in the diagnosis of hilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Hepatic resection and transplantation for peripheral cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Surgical treatment in proximal bile duct cancer. A single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Epithelioid hemangioendothelioma of the liver. A rare hepatic tumor

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry.

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Vascular and rare liver tumors: a good indication for liver transplantation?

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Clinical characteristics and outcome of patients with cirrhosis and refractory ascites

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Diagnosis of portopulmonary hypertension in candidates for liver transplantation: A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver Transplantation for Familial Amyloidotic Polyneuropathy (FAP): A Single-Center Experience Over 16 Years

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Etiology, Management, and Outcome of the Budd-Chiari Syndrome

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Liver transplantation for neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1002%2FLT.22363

21 January 2018

Identifiers

10.1002/LT.22363

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37893109&oldid=1757010663"